Influenza A and B Respiratory syncytial virus (RSV) Coronavirus Disease-2019 (COVID-19) J06.9
Conditions
Interventions
Group 1: The PCR-4-ALL cohort consists of 2 sub-cohorts (observational studies) with different monitoring strategies, which are compared descriptively. The first arm is a sub-cohort of MuSPAD.
MuSPAD
Sponsors
Helmholtz-Zentrum für Infektionsforschung
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: I. A valid declaration of consent from the participants within PIA. This explicitly includes consent to the evaluation and anonymous/aggregated publication of the data collected in the course of the study. II. Willingness to use a smartphone, tablet or computer with internet access as part of the study III. Sufficient knowledge of the German language IV. A valid e-mail address Explicitly for ZIFCO: - Participation in the NAKO health study - Consent for L3 module - at least 20 years
Exclusion criteria
Exclusion criteria: Participants will be excluded if the inclusion criteria are not met. There are no further exclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a.Proportion of tests in which at least one pathogen is found b.Weekly proportion of symptoms reported by participants c. Differences of a) and b) between the arms | — |
Secondary
| Measure | Time frame |
|---|---|
| d. Characteristics of participants in relation to various factors and outcomes, e.g. positive test results and reported symptoms (information for epidemiological modeling) e. Participant satisfaction with the different testing strategies, e.g. characteristics of (rather) satisfied participants e. Comparison of pathogen-specific results with respiratory disease surveillance indicators | — |
Countries
Germany
Contacts
Public ContactStefanie Castell
Helmholtz-Zentrum für Infektionsforschung
Outcome results
None listed